Publications by authors named "Stephen Barron"

Claim this Profile
C
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer.
Agnieszka Krzyzanowska, Debra F Higgins, Stephen Barron, Tony Loughman, Amanda O'Neill

BJUI Compass· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer.
Agnieszka Krzyzanowska, Stephen Barron, Debra F Higgins, Tony Loughman, Amanda O'Neill

Eur Urol Focus· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer.
Tony Loughman, Stephen Barron, Chan-Ju Angel Wang, Peter Dynoodt, Bozena Fender

Clin Chem· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8.
Martin Filipits, Margaretha Rudas, Verena Kainz, Christian F Singer, Florian Fitzal, Stephen Barron

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors.
Seodhna M Lynch, Niamh M Russell, Stephen Barron, Chan-Ju A Wang, Tony Loughman

Eur J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-positive, HER2-negative Breast Cancer Patients.
Claudia Mazo, Stephen Barron, Catherine Mooney, William M Gallagher

Cancers (Basel)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.
Richard Buus, Ivana Sestak, Stephen Barron, Tony Loughman, Bozena Fender

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability and acceptance of the mini-clinical evaluation exercise as a performance assessment of practicing physicians.
Ravi S Sidhu, Rose Hatala, Stephen Barron, Marc Broudo, George Pachev

Acad Med· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disappearance of phantom pain after focal brain infarction.
David Yarnitsky, Stephen A Barron, Ephraim Bental

Pain· March 1988

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis